Atlas Venture Associates XI, LLC
Insider CIK 1780067 · AKRO 10% owner · DYN 10% owner · IKNA 10% owner · XLO 10% owner · DAWN 10% owner · THRD 10% owner · SION 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,298,332 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,051,051 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,092,504 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 61,463 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion deriv | 2025-02-10 | 2025-02-10 | 1,806,317 | — | $0 | 0 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion | 2025-02-10 | 2025-02-10 | 2,886,293 | — | $0 | 2,886,293 | SEC↗ |
| SION Sionna Therapeutics, Inc. | C Conversion | 2025-02-10 | 2025-02-10 | 747,727 | — | $0 | 747,727 | SEC↗ |
| SION Sionna Therapeutics, Inc. | P Buy | 2025-02-10 | 2025-02-10 | 60,000 | $18.00 | $1.08M | 807,727 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-28 | 2024-02-28 | 210 | $25.25 | $5.3K | 864,487 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-28 | 2024-02-28 | 13,109 | $24.83 | $325.5K | 864,697 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-28 | 2024-02-28 | 360 | $25.25 | $9.1K | 1,488,126 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-28 | 2024-02-28 | 22,567 | $24.83 | $560.3K | 1,488,486 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-28 | 2024-02-28 | 2,430 | $25.25 | $61.4K | 5,698,091 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-28 | 2024-02-28 | 152,244 | $24.83 | $3.78M | 5,700,521 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-28 | 40,455 | $24.38 | $986.3K | 1,514,874 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-28 | 2,216 | $24.68 | $54.7K | 877,806 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-28 | 23,505 | $24.38 | $573.1K | 880,022 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-28 | 3,821 | $24.68 | $94.3K | 1,511,053 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-28 | 25,779 | $24.68 | $636.2K | 5,852,765 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-28 | 272,923 | $24.38 | $6.65M | 5,878,544 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 136,312 | $23.59 | $3.22M | 6,216,250 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 64,783 | $23.98 | $1.55M | 6,151,467 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 20,205 | $23.59 | $476.6K | 1,564,932 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 5,580 | $23.98 | $133.8K | 903,527 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 11,736 | $23.59 | $276.9K | 909,107 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 9,603 | $23.98 | $230.3K | 1,555,329 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-23 | 2024-02-23 | 23,648 | $22.70 | $536.8K | 1,585,137 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-23 | 2024-02-23 | 159,542 | $22.70 | $3.62M | 6,352,562 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-23 | 2024-02-23 | 13,738 | $22.70 | $311.9K | 920,843 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-22 | 2024-02-23 | 119,360 | $22.66 | $2.70M | 6,512,104 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-21 | 2024-02-23 | 35,164 | $23.14 | $813.7K | 6,631,464 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-21 | 2024-02-23 | 149,337 | $22.44 | $3.35M | 6,666,628 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-20 | 2024-02-20 | 3,510 | $23.40 | $82.1K | 6,815,965 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-20 | 2024-02-20 | 166,029 | $22.71 | $3.77M | 6,819,475 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-16 | 2024-02-20 | 162,707 | $23.14 | $3.77M | 6,985,504 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-15 | 2024-02-20 | 175,793 | $23.88 | $4.20M | 7,150,324 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | S Sale | 2024-02-15 | 2024-02-20 | 2,113 | $24.45 | $51.7K | 7,148,211 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | S Sale | 2024-02-08 | 2024-02-09 | 733 | $0.64 | $469 | 2,019,563 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | S Sale | 2024-02-08 | 2024-02-09 | 267 | $0.64 | $171 | 734,546 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | S Sale | 2024-01-12 | 2024-01-16 | 1,540 | $0.83 | $1.3K | 2,020,296 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | S Sale | 2024-01-12 | 2024-01-16 | 560 | $0.83 | $465 | 734,813 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | S Sale | 2024-01-11 | 2024-01-16 | 569 | $0.87 | $495 | 735,373 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | S Sale | 2024-01-11 | 2024-01-16 | 1,566 | $0.87 | $1.4K | 2,021,836 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy | 2022-12-12 | 2022-12-14 | 934,581 | $10.70 | $10.00M | 934,581 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion deriv | 2022-09-19 | 2022-09-19 | 2,282,537 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion deriv | 2022-09-19 | 2022-09-19 | 648,447 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion deriv | 2022-09-19 | 2022-09-19 | 594,096 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion deriv | 2022-09-19 | 2022-09-19 | 3,541,390 | — | $0 | 0 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | P Buy | 2022-09-19 | 2022-09-19 | 300,000 | $17.00 | $5.10M | 10,313,763 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion | 2022-09-19 | 2022-09-19 | 6,472,374 | — | $0 | 10,013,763 | SEC↗ |
| THRD Third Harmonic Bio, Inc. | C Conversion | 2022-09-19 | 2022-09-19 | 594,096 | — | $0 | 594,096 | SEC↗ |
| DAWN Day One Biopharmaceuticals | P Buy | 2022-06-17 | 2022-06-22 | 766,667 | $15.00 | $11.50M | 766,667 | SEC↗ |
| IKNA Ikena Oncology, Inc. | S Sale | 2021-12-14 | 2021-12-14 | 5,959 | $14.00 | $83.4K | 1,241,935 | SEC↗ |
| IKNA Ikena Oncology, Inc. | S Sale | 2021-12-13 | 2021-12-14 | 8,330 | $14.64 | $122.0K | 1,247,894 | SEC↗ |
| IKNA Ikena Oncology, Inc. | S Sale | 2021-12-10 | 2021-12-14 | 11,989 | $15.03 | $180.2K | 1,256,224 | SEC↗ |
| DAWN Day One Biopharmaceuticals | C Conversion deriv | 2021-06-01 | 2021-06-02 | 7,761,380 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | C Conversion deriv | 2021-06-01 | 2021-06-02 | 741,396 | — | $0 | 0 | SEC↗ |
| DAWN Day One Biopharmaceuticals | P Buy | 2021-06-01 | 2021-06-02 | 250,000 | $16.00 | $4.00M | 250,000 | SEC↗ |
| DAWN Day One Biopharmaceuticals | C Conversion | 2021-06-01 | 2021-06-02 | 741,396 | — | $0 | 741,396 | SEC↗ |
| DAWN Day One Biopharmaceuticals | C Conversion | 2021-06-01 | 2021-06-02 | 7,761,380 | — | $0 | 7,761,380 | SEC↗ |
| DAWN Day One Biopharmaceuticals | P Buy | 2021-06-01 | 2021-06-02 | 250,000 | $16.00 | $4.00M | 250,000 | SEC↗ |
| IKNA Ikena Oncology, Inc. | P Buy | 2021-03-30 | 2021-12-14 | 125,000 | $16.00 | $2.00M | 874,634 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 5,362,888 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 9,499,999 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 11,258,117 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion deriv | 2021-03-30 | 2021-04-01 | 7,863,094 | — | $0 | 0 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 2,901,609 | — | $0 | 2,901,609 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 749,634 | — | $0 | 749,634 | SEC↗ |
| IKNA Ikena Oncology, Inc. | C Conversion | 2021-03-30 | 2021-04-01 | 1,099,118 | — | $0 | 1,268,213 | SEC↗ |
| DAWN Day One Biopharmaceuticals | P Buy deriv | 2021-02-01 | 2021-06-02 | 741,396 | — | $0 | 741,396 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 20,000,000 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 5,336,179 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 1,608,785 | — | $0 | 1,608,785 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 6,029,726 | — | $0 | 8,140,130 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | C Conversion deriv | 2019-06-24 | 2019-06-25 | 10,666,667 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | C Conversion deriv | 2019-06-24 | 2019-06-25 | 722,737 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2019-06-24 | 2019-06-25 | 270,000 | $16.00 | $4.32M | 505,099 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | C Conversion | 2019-06-24 | 2019-06-25 | 235,099 | — | $0 | 235,099 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | C Conversion | 2019-06-24 | 2019-06-25 | 3,469,759 | — | $0 | 3,469,759 | SEC↗ |